Evidence map›Paper›PMID 31506825›Full record

ArticleBrain structure & function2019

Altered motor, anxiety-related and attentional task performance at baseline associate with multiple gene copies of the vesicular acetylcholine transporter and related protein overexpression in ChAT::Cre+ rats.

Craig P Mantanona, Johan Alsiö, Joanna L Elson, Beth M Fisher, Jeffrey W Dalley, Timothy Bussey, Ilse S Pienaar

Open access · hybridAbstract read
In one paragraph

Article in Brain structure & function, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Bidirectional Modulation of Beam Traversal Performance by Acetylcholine in the Cerebellar Nuclei.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Basal forebrain cholinergic signaling in the basolateral amygdala promotes strength and durability of fear memories.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Craig P MantanonaFaculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.
Johan AlsiöDepartment of Psychology, The Behavioral and Clinical Neuroscience Institute, University of Cambridge, Downing Street, Cambridge, UK.
Joanna L ElsonInstitute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
Beth M FisherDepartment of Psychology, The Behavioral and Clinical Neuroscience Institute, University of Cambridge, Downing Street, Cambridge, UK.
Jeffrey W DalleyDepartment of Psychology, The Behavioral and Clinical Neuroscience Institute, University of Cambridge, Downing Street, Cambridge, UK.
Timothy BusseyDepartment of Psychology, The Behavioral and Clinical Neuroscience Institute, University of Cambridge, Downing Street, Cambridge, UK.
Ilse S PienaarSchool of Life Sciences, University of Sussex, Falmer, BN1 9PH, UK. i.s.pienaar@sussex.ac.uk.
University of Cambridge · GBNewcastle University · GBNorthumbria University · GBUniversity of Sussex · GBWestern University · CA

Funding

Northumbria University PhD award N10093The Rosetrees Trust CDD4507
6 · The paper itself

Abstract

Transgenic rodents expressing Cre recombinase cell specifically are used for exploring mechanisms regulating behavior, including those mediated by cholinergic signaling. However, it was recently reported that transgenic mice overexpressing a bacterial artificial chromosome containing choline acetyltransferase (ChAT) gene, for synthesizing the neurotransmitter acetylcholine, present with multiple vesicular acetylcholine transporter (VAChT) gene copies, resulting in altered cholinergic tone and accompanying behavioral abnormalities. Since ChAT::Cre+ rats, used increasingly for understanding the biological basis of CNS disorders, utilize the mouse ChAT promotor to control Cre recombinase expression, we assessed for similar genotypical and phenotypical differences in such rats compared to wild-type siblings. The rats were assessed for mouse VAChT copy number, VAChT protein expression levels and for sustained attention, response control and anxiety. Rats were also subjected to a contextual fear conditioning paradigm using an unconditional fear-inducing stimulus (electrical foot shocks), with blood samples taken at baseline, the fear acquisition phase and retention testing, for measuring blood plasma markers of hypothalamic-pituitary-adrenal gland (HPA)-axis activity. ChAT::Cre+ rats expressed multiple mouse VAChT gene copies, resulting in significantly higher VAChT protein expression, revealed anxiolytic behavior, hyperlocomotion and deficits in tasks requiring sustained attention. The HPA-axis was intact, with unaltered circulatory levels of acute stress-induced corticosterone, leptin and glucose. Our findings, therefore, reveal that in ChAT::Cre+ rats, VAChT overexpression associates with significant alterations of certain cognitive, motor and affective functions. Although highly useful as an experimental tool, it is essential to consider the potential effects of altered cholinergic transmission on baseline behavior in ChAT::Cre rats.

Indexed as

AnimalsAnxietyAttentionBrainConditioning, ClassicalFearGene DosageHypothalamo-Hypophyseal SystemMaleMice, Inbred C57BLMice, TransgenicMotor ActivityRats, Long-EvansRats, TransgenicVesicular Acetylcholine Transport ProteinsSlc18a3 protein, mouseVesicular Acetylcholine Transport Proteins5-CSRTTChAT::Cre ratsCre-recombinaseHPA endocrine axisTouchscreen-based behavioral testingVesicular acetylcholine transporter

Identifiers

PMID31506825
PMCPMC6875150
OpenAlexW2972371513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.